Novo Nordisk to terminate GLP-1 patch collaboration agreement with Zosano Pharma
Zosano Pharma Corporation, a clinical-stage specialty pharmaceutical company, announced that Novo Nordisk has notified Zosano of its intention to discontinue the collaboration... Read More